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ABSTRACT
Brown adipose tissue uncoupling protein-1 (UCP1) plays a
major role in the control of energy balance in rodents. It has
long been thought, however, that there is no physiologically
relevant UCP1 expression in adult humans. In this study we
show, using an original approach consisting of sorting cells
from various tissues and differentiating them in an adipo-
genic medium, that a stationary population of skeletal mus-
cle cells expressing the CD34 surface protein can differen-
tiate in vitro into genuine brown adipocytes with a high level
of UCP1 expression and uncoupled respiration. These cells
can be expanded in culture, and their UCP1 mRNA ex-
pression is strongly increased by cell-permeating cAMP
derivatives and a peroxisome-proliferator-activated re-
ceptor- (PPAR) agonist. Furthermore, UCP1 mRNA
was detected in the skeletal muscle of adult humans, and
its expression was increased in vivo by PPAR agonist
treatment. All the studies concerning UCP1 expression in
adult humans have until now been focused on the white
adipose tissue. Here we show for the first time the exis-
tence in human skeletal muscle and the prospective iso-
lation of progenitor cells with a high potential for UCP1
expression. The discovery of this reservoir generates a
new hope of treating obesity by acting on energy dissipa-
tion. STEM CELLS 2008;26:2425–2433
Disclosure of potential conflicts of interest is found at the end of this article.
INTRODUCTION
Uncoupling protein-1 (UCP1) is the main effector of adaptative
thermogenesis in rodents. Specifically expressed in brown adi-
pose tissue (BAT) mitochondria, UCP1 acts as an uncoupler of
oxidative phosphorylation and dissipates energy as heat. BAT
thermogenesis in rodents is increased upon exposure to low
temperature or as a result of overeating. It is controlled by the
sympathetic nervous system that stimulates mitochondriogen-
esis and UCP1 expression and activity [1]. BAT therefore plays
an important role in the maintenance of body temperature and
energy balance [2, 3]. In rodents, ectopic brown adipocytes can
also be found, outside the BAT, in white adipose tissue (WAT)
depots [4]. Their emergence is induced by cold acclimation
[5–7] and 3-adrenoceptor agonist administration [7, 8]. Ectopic
WAT brown adipocytes might act in synergy with the BAT to
prevent obesity [7, 8].
In humans, typical BAT expressing UCP1 is present in
neonates but was considered until recently to disappear early in
life [9, 10]. In adult humans few brown adipocyte progenitors
still exist in the WAT, which can be induced to differentiate into
UCP1-expressing cells in vitro by -adrenoceptor agonists [11]
and thiazolidinediones [12] or in vivo in the vicinity of cate-
cholamine-secreting pheochromocytomas [13]. Because of its
scarcity, however, this candidate dormant population cannot be
considered a reliable source for brown adipocyte reappearance
in humans.
Recently, however, there has been a resurgence of interest in
the hypothesis that BAT might play a role in adult humans.
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Indeed, fluorodeoxyglucose positron emission tomography
studies allowed visualizing in humans highly dynamic adipose
tissue depots in the upper part of the body. Their metabolism
was stimulated by cold exposure and inhibited by -blockers.
These depots were proposed to represent BAT that had been
undetected until now [14]. Many more studies are needed to
define ex vivo the metabolic profile and in vivo the possible
physiological role of these BAT depots in adult humans.
Furthermore, a study performed in mice showed, recently,
the presence of ectopic brown adipocytes expressing UCP1 in
the skeletal muscle. This study also showed that the number of
UCP1-positive cells and the level of UCP1 mRNA in the muscle
were higher in obesity-resistant 129S6 mice than in obesity-
prone C57BL6 mice and suggested that the muscle ectopic BAT
deposits reflect a genetic mechanism of protection against
weight gain [15]. However, the observation that neither 129S6
nor C57BL6 mice respond to high-fat feeding by an upregula-
tion of UCP1 expression in their muscle does not support this
hypothesis [16]. In a different field, liver X receptor-null mice
have been reported to be obesity-resistant. Intriguingly, an up-
regulation of UCP1 expression and an uncoupled oxidative
phosphorylation were observed in their skeletal muscle [17].
The novel uncoupling proteins UCP2 and UCP3, abundantly
expressed in human tissues, were first considered as thermo-
genic proteins [18, 19]. It is, however, now generally admitted
that they are not involved in adaptative thermogenesis [20]. The
gold-standard thermogenic uncoupling protein, therefore, re-
mains UCP1.
Before the review of Nedergaard et al. [14] reporting the
existence of BAT-like depots in adult humans and the study of
Almind et al. [15] showing the occurrence of brown adipocyte
ectopic depots outside the WAT, we had started an independent
study with the aim of identifying in human tissues possible
progenitors of brown adipocytes that might differentiate in
culture into mature cells expressing UCP1.
It has been shown that subsets of vascular cells (i.e., endothelial
cells and pericytes) are a source of multilineage progenitors in
human tissues [21–23]. The surface antigens CD34, which is ex-
pressed by both hematopoietic progenitors and vascular endothelial
cells [24], and CD146, a marker of the pericytes that surround the
endothelial layer in capillaries and microvessels [25], were chosen
to sort progenitors and endothelial cells on one hand and pericytes
on the other. The potential of each of these cell populations, sorted
from various human fetal and adult tissues and grown in an adi-
pogenic medium, to differentiate in culture into brown adipocytes
was tested. It was found that CD34 cells from skeletal muscle but
not from WAT display the unique capacity to differentiate in vitro
into genuine brown adipocytes with a high level of UCP1 expres-
sion. The dormant muscle CD34 cell population might prove a
reliable target for brown adipocyte resurgence in humans.
MATERIALS AND METHODS
Materials
All organic and inorganic chemicals of analytical or molecular
biology grade were purchased from Sigma-Aldrich (St. Louis,
http://www.sigmaaldrich.com) and Gibco-BRL (New York, http://
www.gibcobrl.com).
Human Tissues
Human fetal tissues were obtained anonymously, following spon-
taneous, voluntary, or therapeutic terminations of pregnancy, from
Magee-Womens Hospital, University of Pittsburgh, in compliance
with the institutional review board protocol. Developmental age
(16–24 weeks of gestation) was estimated by measuring foot length.
Informed consent to the use of fetal tissues was obtained from the
patients in all instances. Adult human discarded abdominal subcu-
taneous WAT, originating from 45–55-year-old patients undergoing
plastic surgery performed 1 year after gastric bypass, was kindly
provided by Dr. Peter Rubin (Division of Plastic Surgery, Univer-
sity of Pittsburgh). The adult skeletal muscle used for cell sorting
was obtained post mortem from 50–78-year-old donors. The adult
skeletal muscle used for the first group of reverse transcription
(RT)-polymerase chain reaction (PCR) studies was obtained from
the rectus abdominus during surgery for either lap banding, inguinal
hernia, or hysterectomy of 10 lean male and female subjects. All
subjects agreed to donate muscle samples during their operations,
and the protocol was approved by the Medical Ethical Review
Committee of Deakin University. The average age was 45  3
years, and the average body mass index was 22.2  0.8. The adult
skeletal muscle used for the second group of RT-PCR studies was
obtained from the vastus lateralis of seven obese type 2 diabetic
male and female subjects before and after 8 weeks of treatment with
rosiglitazone (two doses of 4 mg each per day). The average age
was 63 4 years, and the average body mass index was 29.9 3.8.
The complete clinical profile of the patients has been described in a
previous publication [26]. All subjects agreed to donate muscle
samples, and the protocol was approved by the Medical Ethical
Review Committee of Maastricht University.
Mice
Animals were treated in accordance with the Centre Me´dical Uni-
versitaire (Geneva, Switzerland) institutional guidelines. They were
housed individually and kept on a 12-hour light-dark cycle in a
temperature-controlled room at 24°C. They were allowed ad libitum
access to water and a standard laboratory chow. The interscapular
BAT of 4–6-week-old male 129 Sv/ev mice was excised, and their
precursor cells were isolated and cultured as previously described
[27].
Immunohistochemistry
Fresh fetal and adult tissues were gradually frozen by immersion in
isopentane cooled in liquid nitrogen. Five- to 7-m sections were
cut on a cryostat (Microm HM 505 E [Mikron Instrument Company,
Inc., Oakland, NJ, http://www.mikron.com]), fixed with 50% ace-
tone and 50% methanol, dried for 5 minutes at room temperature,
and then washed three times for 5 minutes in phosphate-buffered
saline. Nonspecific binding sites were blocked with 5% goat serum
for 1 hour at room temperature. Sections were incubated overnight
at 4°C with a CD34 mouse anti-human antibody (1:50; AbD Sero-
tec, Raleigh, NC, http://www.ab-direct.com) and then, after rinsing,
for 1 hour at room temperature with a secondary goat anti-mouse
biotinylated antibody (1:1,000; Dako, Glostrup, Denmark, http://
www.dako.com) and for 30 minutes at room temperature with
streptavidin-Cy3 (1:1,000; Sigma-Aldrich) or for 2 hours at room
temperature with a conjugated CD146-Alexa 488 mouse anti-hu-
man antibody (1:200; Chemicon, Temecula, CA, http://www.
chemicon.com). Nuclei were stained with 4, 6-diamino-2-phenylin-
dole dihydrochloride (1:2,000; Molecular Probes, Eugene, OR,
http://probes.invitrogen.com) for 5 minutes at room temperature. An
isotype-matched negative control was performed with each immu-
nostaining.
Flow Cytometry
The vascular cells of fetal skeletal muscle, pancreas, lung, and liver,
as well as those of adult muscle and WAT, were analyzed by flow
cytometry. Fresh fetal and adult muscle, as well as fetal pancreas,
lung, and liver tissues, were cut into small pieces with a scalpel in
Dulbecco’s modified Eagle’s medium (DMEM) high-glucose con-
taining 20% fetal bovine serum (FBS), 1% penicillin-streptomycin
(PS), and collagenases IA-S, II-S, and IV-S (1 mg/ml) and then
incubated at 37°C for 75 minutes (fetal tissues) or 90 minutes (adult
tissues) with constant stirring. Final cell dissociation was achieved
between ground-glass slides. Cells were washed with phosphate-
buffered saline and centrifuged for 5 minutes at 350g. They were
resuspended in DMEM, 20% FBS; filtered at 100 m; stained with
trypan blue; and counted after dead cell exclusion. The WAT stroma
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vascular fraction was prepared by collagenase digestion according
to Champigny et al. [28]. Cells (105 cells for analysis and approx-
imately 30  106 cells for sorting) were incubated with one of the
following directly coupled mouse anti-human antibodies: CD45-
APC Cy7 (1:200; Santa Cruz Biotechnology Inc., Santa Cruz, CA,
http://www.scbt.com), CD56-PE Cy7 (1:100; BD Pharmingen, San
Diego, http://www.bdbiosciences.com/index_us.shtml), CD34-PE
(1:100; Dako), and CD146-fluorescein isothiocyanate (FITC) (1:
100; AbD Serotec) in 1 ml of DMEM, 20% FBS, 1% PS, at 4°C for
15 minutes. After washing and centrifugation, cells were incubated
for 30 minutes with 7-aminoactinomycin D (1:100; BD Pharmin-
gen) for dead cell exclusion, filtered at 70 m, and run on a
FACSAria flow cytometer (Becton, Dickinson and Company,
Franklin Lakes, NJ, http://www.bd.com). As negative controls, cell
aliquots were incubated with isotype-matched mouse IgGs conju-
gated to APC Cy7 (1:100; BD Pharmingen), PE Cy7 (1:100; BD
Pharmingen), PE (1:100; Chemicon), and FITC (1:100; United
States Biological, Swampscott, Massachusetts, http://www.usbio.
net) under the same conditions.
Cell Culture
Cells were seeded at 2  104 cells per cm2 in 0.2% gelatin-coated
plates and cultured until confluence (4–6 days) at 37°C in EGM2
medium (Cambrex, Walkersville, MD, http://www.cambrex.com)
and until differentiation (8–12 more days) in a modification of the
adipogenic medium described by Rodriguez et al. [29] consisting of
DMEM-Ham’s F-12 medium containing 0.86 M insulin, 10 g/ml
transferrin, 0.2 nM triiodothyronine, 1 M rosiglitazone (Glaxo-
SmithKline, Research Triangle Park, NC, http://www.gsk.com),
100 M 3-isobutyl-1-methylxanthine, 1 M dexamethazone, and
1% PS. For cell expansion studies, confluent cells grown in EGM2
medium only were detached by treatment with trypsin-EDTA for
3–5 minutes at 37°C and then split 1:3 and cultured as described
above. Human white adipocytes in primary culture used in the
oxymetry studies were obtained as previously described [30].
RT-PCR
Total cell RNA was prepared using the NucleoSpin RNAII kit
(Clontech, Palo Alto, CA, http://www.clontech.com) or Extract-all
solution (Eurobio, Les Ulis, France, http://www.eurobio.fr) and
quantified by biophotometry (BioPhotometer; Eppendorf AG, Ham-
burg, Germany, http://www.eppendorf.com). Oligo(dT)-primed
first-strand cDNA was synthesized using the Superscript II RNase
H Reverse Transcription kit (Invitrogen, Carlsbad, CA, http://www.
invitrogen.com) and oligo(dT) primers or the High Capacity cDNA
Reverse Transcription kit (Applied Biosystems, Foster City, CA,
http://www.appliedbiosystems.com) and random primers. Quantita-
tive real-time RT-PCR was performed using the ABI rapid thermal
cycler system and a SYBR Green PCR master mix (Applied Bio-
systems). Cyclophilin A was used as a control to account for any
variations due to the efficiency of the reverse transcription. The
upstream and downstream oligonucleotide primers were chosen on
both sides of an intron to prevent amplification of contaminating
genomic DNA. The primers used for quantitative RT-PCR in human
cells and in mouse brown adipocytes are described in supplemental
online Table 1, those used for quantitative RT-PCR in human
skeletal muscle are described in supplemental online Table 2, and
those used for analytical RT-PCR are described in supplemental
online Table 3.
Validation of the Human UCP1 Amplicon
The PCR-amplified fragment was cloned into the pCR2.1-TOPO
vector through the TOPO-TA cloning system (Invitrogen), and
purification of color-selected colonies was performed using the
Qiaprep Spin Miniprep (Qiagen, Hilden, Germany, http://www1.
qiagen.com). Sequences were determined with oligonucleotide M13
Reverse on the pCRII-TOPO vector using the Applied Biosystems
Big Dye sequencing kit on an ABI 3700 automated sequencer
(Applied Biosystems).
Western Blots
Cultured cells were collected with a rubber policeman in 200 l of
RIPA buffer (150 mM NaCl, 1% Nonidet P-40, 0.5% sodium
deoxycholate, 0.1% SDS, 1:200 protease inhibitor cocktail [Sigma-
Aldrich], and 50 mM Tris-HCl, pH 8.0). Human BAT and skeletal
muscle were homogenized in the above RIPA buffer. The protein
content was determined according to the technique of Lowry et al.
[31]. Western blots were performed as previously described [32].
The UCP1 protein was detected using a 1:500 diluted rabbit anti-
mouse UCP1 polyclonal primary antibody generously provided by
Dr. B. Cannon (Stockholm, Sweden). This antibody had been raised
against the C-terminal decapeptide of mouse UCP1, which shares
80% identity with human UCP1 and 0% and 10% identities with
human UCP2 and UCP3, respectively. Glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) protein was detected using a 1:5,000
diluted mouse anti-mouse GAPDH monoclonal primary antibody
(Chemicon). Also used were 1:5,000 diluted goat anti-rabbit or
anti-mouse peroxidase-labeled secondary antibodies (Sigma-Al-
drich or Bio-Rad [Hercules, CA, http://www.bio-rad.com]). A See-
Blue Plus 2 Pre-stained Standard Ladder (Invitrogen) was used.
Protein signals were detected by chemiluminescence using a stan-
dard ECL kit and developed on a Hyperfilm ECL film (GE Health-
care, Chicago, http://www.gehealthcare.com).
High-Resolution O2 Consumption Measurement
Oxygen consumption was measured using a two-injection-chamber
respirometer equipped with a Peltier thermostat, Clark-type elec-
trodes, and integrated electromagnetic stirrers (Oroboros Oxygraph;
Oroboros, Innsbruck, Austria, http://www.mitophysiology.org).
Measurements were performed at 37°C with continuous stirring in
2 ml of DMEM-Ham’s F-12 medium, 10% newborn calf serum.
Under these conditions, the serum provided the fatty acids necessary
to sustain UCP1 uncoupling activity [10]. Before each O2 consump-
tion measurement, the medium in the chambers was equilibrated
with air for 30 minutes, and freshly trypsinized cells were trans-
ferred into the respirometer glass chambers. After steady-state re-
spiratory flux was observed, ATP synthase was inhibited with
oligomycin (0.25–0.5 mg/l), and cells were titrated with the uncou-
pler carbonyl cyanide 3-chlorophenylhydrazone up to optimum
concentrations in the range of 1–2 M. The respiratory chain was
inhibited by antimycin A (1 g/ml). Oxygen consumption was
calculated using DataGraph software (Oroboros).
Microarray Analysis
The total RNA of fetal muscle CD34 cells expanded in culture for
up to three passages (4 weeks) and of human muscle biopsies were
prepared as described above. The quality assurance measurements,
the preparation of the cRNA targets, and the microarray analyses
using the Illumina Human WG-6 BeadChip (Illumina Inc., San
Diego, http://www.illumina.com) were performed by Expression
Analysis (Durham, NC, http://www.expressionanalysis.com). Bead-
Studio nonparametric methods were used for the computation of
detection p values.
Statistical Analysis
Data are expressed as means  SEM. Significances were evaluated
using the unpaired Student’s t test. A paired Student’s t test was
used to determine the effects of rosiglitazone on human skeletal
muscle UCP1 mRNA levels. Significances were set at p  .05.
RESULTS
Sorting of Muscle Vascular Cells
In fetal skeletal muscle, CD34 and CD146 were found, by
immunohistochemistry, to be expressed at the surfaces of endo-
thelial cells and pericytes, respectively, although CD34 was also
expressed by cells scattered in the intermyofibrillar space (Fig.
1A). A similar distribution of CD34 and CD146 cells was
observed in adult skeletal muscle (not shown). We next sorted
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vascular cells from seven independent fetal muscles (16–24
weeks of gestation) using multicolor fluorescence-activated cell
sorting (FACS). Hematopoietic (CD45) cells were first gated
out, as were myogenic progenitors (CD56). Then, endothelial
cells (CD34/CD146) and pericytes (CD34/146) were
sorted. The CD34/CD146/CD45/CD56 were thereafter
designated CD34 cells, and the CD34/CD146/CD45/
CD56 were designated CD 146 cells. The CD34 cells
amounted to 8%  1% of the starting fetal muscle cell popu-
lation (Fig. 1B) and were shown by RT-PCR analysis not to be
contaminated by detectable CD45 hematopoietic or CD56
myogenic cells (Fig. 1C).
The sorted cells were grown under conditions that sustained
optimal white adipocyte differentiation in WAT primary cul-
tures (i.e., 4–6 days in EGM2 medium and 8–12 days in the
adipogenic medium, as described in Materials and Methods).
Virtually all sorted fetal muscle CD34 cells differentiated into
adipocyte-like multilocular cells (Fig. 2A). It is noteworthy that
in cell culture, the multilocular structure is shared by white and
brown adipocytes. In contrast, fetal muscle CD146 cells grew
very slowly under the conditions described above. They did not
reach cell confluence and displayed a pericyte-like appearance
Figure 1. Immunohistochemical description and fluorescence-acti-
vated cell sorting analysis and sorting of vascular cells in human fetal
muscle. (A): In a small vessel longitudinal section, CD146 pericytes
(green) surround CD34 endothelial cells (red). Scale bar  50 M.
(B): CD34/CD146 and CD34/CD146 cell purification. Disso-
ciated cells were stained with PE-anti-CD34, FITC-anti-CD146, PE-
Cy7-anti-CD56, and APC-Cy7-anti-CD45 antibodies and run on a FAC-
SAria cell sorter. Following exclusion of CD45 and CD56 cells (left
panels), cells inside the CD34 or CD146 gates were sorted. (C):
Reverse transcription-polymerase chain reaction analysis of CD34/
CD146/CD45/CD56 (CD34), CD34/CD146/CD45/CD56
(CD146), and total nonsorted cells. -actin mRNA was measured as a
control. Abbreviation: FITC, fluorescein isothiocyanate.
Figure 2. Culture under adipogenic conditions of cells sorted from
human fetal muscle. CD34 (A) or CD146 (B, C) cells in PC and
CD34 (D) cells expanded in culture up to P3. All the cells were grown
for 4–6 days in EGM2 medium and then placed for 8–12 days in the
adipogenic medium described in Materials and Methods. Numerous
adipocytes developed from CD34 (A, D) but not from CD146 cells
(B, C). Shown are phase-contrast images. Scale bar  50 m. (E):
Quantitative reverse transcription polymerase chain reaction determina-
tion of UCP1 (open columns) and leptin (gray columns) mRNA expres-
sion in CD34 cells in PC or expanded up to P3. The results are the
mean  SEM of arbitrary values normalized using the corresponding
cyclophilin A values. n  4–7. (F): Representative Western blot anal-
ysis of UCP1 and GAPDH proteins in tissue or whole cell extracts.
Shown are interscapular brown adipose tissue of a 19-week fetus (lane
1) and CD34 cells in PC (lane 2) or skeletal muscle of an adult human
(lane 3). On each lane, 25 g of proteins was loaded. Abbreviations:
GAPDH, glyceraldehyde 3-phosphate dehydrogenase; kD, kilodaltons;
P3, passage 3; PC, primary culture; UCP1, uncoupling protein-1.
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characterized by a large size, spread-out shape, and irregular
borders (Fig. 2B, 2C). Occasional multilocular cells could be
detected (Fig. 2C) The morphology of CD34 cells expanded in
culture for up to three passages (4 weeks) under the conditions
described above was similar to that observed in primary culture,
although the size of mature adipocytes was smaller (Fig. 2C).
UCP1 Expression in Cultivated CD34 Cells
The remarkable adipocyte-like differentiation of fetal muscle
CD34 cells was an incentive for further characterization.
Strikingly, quantitative RT-PCR revealed a high level of UCP1
mRNA in these cells. The mean UCP1 mRNA level normalized
with cyclophilin A was 1,797 510 arbitrary units, correspond-
ing to a Ct of 22 for 25 ng of cDNA in the assay (Fig. 2E). For
comparison, the mean UCP1 mRNA level normalized with
cyclophilin A in mouse brown adipocytes differentiated in cul-
ture was 7,715  2,649 (n  10) arbitrary units (not shown).
Therefore, the level of UCP1 mRNA in human CD34 cells
amounted to almost one-fourth that in mouse brown adipocytes
in culture. It should be noted that the human fetus BAT could
not be used as a positive control for quantitative RT-PCR
analysis since, because of the time elapsed after the termination
of the pregnancy, the risk of RNA degradation was too high.
The amplicon was cloned and sequenced and found to be 100%
homologous to human UCP1 gene. In fetal muscle CD34 cells
expanded up to passage 3, a high UCP1 mRNA expression,
amounting to 43% of that detected in primary cultured cells, was
still observed. UCP1 mRNA expression was not detected in
nondifferentiated fetal muscle CD34 cells or in CD146 cells
in primary culture. The level of leptin mRNA was 9.9 5.5 and
71  52 arbitrary units in primary cultured and expanded cells,
respectively (Fig. 2E).
Further Phenotyping of the CD34 Cells
To better characterize the gene expression pattern of the fetal
muscle CD34 cells expanded in culture, a microarray analysis
was performed. The levels of expression of several representa-
tive gene mRNAs with significant detection p values (p  .01)
are shown in Table 1 and compared with those in human muscle
biopsies. The mRNAs of the genes coding for the following
proteins were chosen: UCP1 as a reference; mitochondrial tran-
scription factor A (mtTFA), peroxisome-proliferator-activated
receptor- (PPAR), and PPAR coactivator-1 (PGC-1),
which are involved in the control of thermogenesis and mito-
chondriogenesis [33, 34]; enzymes of the mitochondrial respi-
ratory chain cytochrome oxidase IV (COX IV) and succinate
dehydrogenase (SDH); enzymes of the fatty acid degradation
pathway carnitine palmitoyltransferase 1B (CPT1B), acyl-coen-
zyme A dehydrogenase long chain (ACAD), and C-4 to C-12
straight chain (ACADM); and the skeletal muscle markers myo-
genin, myogenic factor 5 (Myf5), and myogenic differentiation1
(MyoD1). Cidea, which is highly expressed in the BAT, where
it acts as a suppressor of UCP1 activity [35], was chosen as a
BAT marker. The accession numbers of the corresponding
genes are shown in the supplemental online data.
UCP1 was significantly expressed in fetal muscle-expanded
CD34 cells but not in adult muscle biopsies. The levels of
mRNA expressions of the selected genes in fetal muscle-ex-
panded CD34 cells are comparable with those of the adult
muscle biopsies, with the exception of PGC-1 and CPT1B
mRNAs, which are approximately 5-fold less expressed in the
cells, and of the PPAR and ACAD mRNAs, which are 40- and
7-fold less expressed, respectively, in the muscle. The muscle
markers myogenin, Myf5, and MyoD1 mRNA were signifi-
cantly expressed in the muscle but not in the cells, whereas the
BAT marker Cidea mRNA was expressed in the cells but not in
the muscle. No 3-adrenoceptor mRNA could be detected in the
microarray analysis. It is noteworthy, however, that 3-adreno-
ceptor mRNA was detected by quantitative RT-PCR (arbitrary
value, 0.084  0.044 with cyclophilin A as a reference; n  4)
in fetal muscle CD34 cells in primary culture. Measurements
of mtTFA, PGC1-, and COX IV mRNA content were also
performed by quantitative RT-PCR to check the microarray data
by another technique. The results were confirmatory, showing in
fetal muscle CD34 cells in primary culture, using cyclophilin
A as a reference, high mtTFA, PGC1-, and COX IV mRNA
levels amounting to 306  117, 385  294, and 23,400 
10,300 arbitrary units (n  3–4), respectively. The UCP1 pro-
tein, as assessed by Western blotting with an anti-mouse anti-
body cross-reacting with human UCP1 (80% identity), was as
abundant in primary cultured fetal muscle CD34 cells as in
fetal BAT (Fig. 2F).
Uncoupling of Oxidative Phosphorylation
To get insight into the possible function of UCP1 in muscle-
derived cells, mitochondrial respiration of isolated cultured hu-
man fetal muscle CD34 cells and human adult white adipo-
cytes was compared. Basal respiration was defined as the
antimycin A-sensitive oxygen consumption. Uncoupled respira-
tion was defined as the percentage of basal respiration insensi-
tive to the ATP synthase blocker oligomycin. The ratios of
uncoupled to total respiration were 47%  12% and 19%  2%
in human fetal muscle CD34 cells and adult white adipocytes,
respectively (Fig. 3A).
Modulations of UCP1 Expression in Cultivated
CD34 Cells
UCP1 mRNA expression in fetal muscle CD34 cells could be
modulated by drug treatment. Cell-permeating cAMP deriva-
tives strongly stimulated (7–8-fold) UCP1 mRNA expression in
both primary cultured and expanded cells (Fig. 3B). PPAR
agonists increase UCP1 expression in rodent BAT [36]. Ros-
iglitazone, a PPAR agonist, had no effect in primary culture
cells but strongly stimulated (eightfold) UCP1 mRNA expres-
sion in expanded cells (Fig. 3C).
Table 1. Levels of expressions of selected gene mRNAs
Selected
mRNAs CD34 cells
Human muscle
biopsies
UCP1 94 NS
mTFA 413 205
PPAR 3,326 84
PGC-1 137 619
COX IV 13,082 13,407
SDH 2,390 5,187
CPT1B 99 639
ACAD 1,032 141
ACADM 599 1,640
Myogenin NS 267
Myf5 NS 21
MyoD NS 12
Cidea 337 NS
The data are expressed as the average Illumina signal in arbitrary
units. The detection p values were .01.
Abbreviations: ACAD, acyl-coenzyme A dehydrogenase long
chain; ACADM, C-4 to C-12 straight chain; COX IV, cytochrome
oxidase IV; CPT1B, carnitine palmitoyltransferase 1B; mtTFA,
mitochondrial transcription factor A; Myf5, myogenic factor 5;
MyoD1, myogenic differentiation 1; NS, not significant; PGC-1,
peroxisome proliferator-activated receptor- coactivator-1;
PPAR, peroxisome proliferator-activated receptor-; SDH,
succinate dehydrogenase; UCP1, uncoupling protein-1.
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Muscle Specificity and Persistence Throughout Life
of Human Brown Adipocyte Progenitors
The derivation of UCP1-expressing cells from human fetal
muscle raised the question of the restriction of brown adipocyte
progenitors to this tissue and to the fetal stage. To address this
issue, CD34 cells purified by FACS from human fetal pan-
creas, lung, and liver were cultured under the same adipogenic
conditions as fetal muscle CD34 cells. The sorted cells grew
slowly, and only a small proportion of them became multiloc-
ular. UCP1 mRNA was not expressed in pancreas or lung cells;
however, a minor expression was measured in liver cells, which
amounted to 2% of that detected in fetal muscle CD34 cells
(not shown).
CD34 cells sorted from four adult (50–78 years) human
skeletal muscle samples, grown in primary culture under adipo-
genic conditions, also differentiated into multilocular cells.
These cells were interspersed with other types of cells, some of
them containing small lipid droplets (Fig. 4A). The level of
UCP1 mRNA (370  132 arbitrary units) was 21% of that
detected in primary cultured fetal muscle CD34 cells. In
contrast, leptin expression (75 69 arbitrary units) was 7.6-fold
Figure 3. Uncoupling of mitochondrial respiration and control of
UCP1 mRNA expression in human fetal muscle CD34 cells. (A):
Uncoupling of mitochondrial respiration in isolated fetal muscle
CD34 cells and in human adult white adipocytes grown in PC and
freshly trypsinized. The results are means  SEM. , p  .05; n  3.
(B): Effects of the cAMP derivatives 8-bromo-cAMP (0.25 mM) and
(4-chlorophenylthio)-cAMP (0.25 mM) (cAMP) on UCP1 mRNA ex-
pression in CD34 cells in PC or expanded up to P3. All the cells were
grown for 4–6 days in EGM2 medium and then placed for 8–12 days
in the adipogenic medium described in Materials and Methods. The
results are means  SEM of arbitrary values normalized using the
corresponding cyclophilin A values. Results are expressed in percentage
of the respective untreated (control) values, considered as 100%. , p 
.05; n  3–6. (C): Effects of 1 M rosi on UCP1 mRNA expression in
CD34 cell PC or P3. The results are expressed as in (B). , p  .01;
n  4–7. Abbreviations: P3, passage 3; PC, primary culture; rosi,
rosiglitazone; UCP1, uncoupling protein-1.
Figure 4. Characterization of adult muscle and WAT cells in adipo-
genic culture. (A): Human adult muscle CD34 cells in PC. Shown is
a phase-contrast image. Scale bar  50 m. (B): Quantitative reverse
transcription polymerase chain reaction determination of UCP1 (open
column) and leptin (gray column) mRNA expression. All the cells were
grown for 4–6 days in EGM2 medium and then placed for 8–12 days
in the adipogenic medium described in Materials and Methods. The
results are the mean  SEM of arbitrary values normalized using the
corresponding cyclophilin A values. n  4–5. (C): Adult human WAT
CD34 cells in PC. Shown is a phase-contrast image. Scale bar  50
m. Abbreviations: PC, primary culture; UCP1, uncoupling protein-1;
WAT, white adipose tissue.
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higher than in fetal cells (Fig. 4B). CD34 cells sorted from
four adult (45–55 years) human WAT samples were also grown
in primary culture under adipogenic conditions. They became
partially multilocular (Fig. 4C) but did not express UCP1
mRNA.
Detection of UCP1 mRNA Expression in Human
Muscle and Effect of Rosiglitazone In Vivo
It was interesting to investigate the possibility that brown adi-
pocyte progenitors of the adult human skeletal muscle can
differentiate in vivo and give rise to UCP1-expressing cells. The
presence of UCP1 mRNA in the adult human skeletal muscle
was tracked using a high-sensitivity quantitative RT-PCR tech-
nique, and in fact, low levels of UCP1 mRNA were detected in
the rectus abdominus muscle of 10 lean subjects (UCP1/cyclo-
philin A ratio, 24 9; not shown). The PCR-amplified fragment
was sequenced and found to be 100% homologous to human
UCP1 gene. The UCP1 mRNA level in adult human muscle was
75-fold lower than that in fetal muscle CD34 cells in culture.
Since the PPAR agonist rosiglitazone was a strong inducer
of UCP1 mRNA expression in muscle CD34 cells in culture,
it seemed of interest to investigate the possible effect of this
compound in vivo in humans. Vastus lateralis muscle biopsies
from seven obese patients with type 2 diabetes mellitus treated
for the management of their metabolic syndrome with rosigli-
tazone were used. The biopsies were obtained before and after
8 weeks of treatment with rosiglitazone (two doses of 4 mg each
per day). As shown in Figure 5, the muscle UCP1 mRNA level
was increased 1.6-fold by the roziglitazone treatment. Strong
effects of rosiglitazone, varying between 1.5- and 4.1-fold, were
observed in four of seven patients.
DISCUSSION
In the present study we demonstrated the existence, in human
fetal and adult skeletal muscle, of a stationary population of
cells expressing the CD34 surface protein and able to differen-
tiate in vitro into genuine brown adipocytes expressing a high
level of UCP1 mRNA. The potential of the CD34 cells to
differentiate into brown adipocytes was preserved throughout
development and aging, although the UCP1/leptin ratio became
smaller after expansion of the cells, suggesting a shift toward a
white adipocyte phenotype. In immortalized HB2 brown adipo-
cytes, UCP1 mRNA expression was found to diminish gradually
upon repeated passages [37]. This loss and that observed in this
study could be due to a negative growth advantage of cells with
uncoupled respiration.
Measurements of mRNA transcripts by microarray in dif-
ferentiated fetal muscle CD34 cells first confirmed the expres-
sion of UCP1 mRNA previously evidenced by quantitative
RT-PCR. It also suggested that these cells are well equipped in
thermogenic transcription factors (PPAR and PGC-1) and,
despite an adipocyte-like morphology, contain levels of mito-
chondria (COX IV and SDH) and of fatty acid degradation
(CPT1B, ACAD, and ACADM) enzyme mRNAs that are of the
same order of magnitude as those found in skeletal muscle. The
lack of a detectable expression of myogenin, Myf5, and MyoD1
in differentiated CD34 cells suggests that the adipogenic
culture conditions used in this study are not permissive for
muscle-specific gene expression. It is noteworthy that muscle
CD34 and, to a larger extent, CD146 cells grown in a
myogenic medium can differentiate into myocytes in vitro and
in vivo [38]. The 3-adrenoceptor, which, in rodents, is consid-
ered an adipocyte-specific -adrenoceptor subtype [39], was
expressed in the CD34 cells, although at a low level. The
presence of the 3-adrenoceptor had been reported in humans
only in newborn BAT [40] and in infant BAT immortalized cells
[41]. Finally, Cidea mRNA expression confirmed the brown
adipocyte nature of the CD34 cells.
The part of the respiration that was uncoupled was higher in
differentiated fetal muscle CD34 cells than in adult white
adipocytes. This observation suggests that UCP1 is functional
and uncouples mitochondrial respiration in muscle-derived
cells, behaving as a genuine uncoupling protein.
Cell-permeating cAMP derivatives and the PPAR agonist
rosiglitazone strongly stimulated UCP1 mRNA expression in
expanded CD34 cells, demonstrating the existence of cAMP
signaling and the possibility of increasing UCP1 expression by
specific -adrenoceptor and PPAR agonists in these cells. The
observation that rosiglitazone had no effect on cells in primary
culture is difficult to explain. It might be that the basal UCP1
mRNA expression, by decreasing upon cell expansion, becomes
more susceptible to an upregulation by rosiglitazone.
Since in rodents, the presence of ectopic brown adipocytes
in the WAT, as well as the possibility of increasing their number
under conditions of high thermogenic needs such as cold accli-
mation, is well documented [5–7], we anticipated finding brown
adipocyte progenitors in the adult human WAT. It should be
mentioned that the absence of brown adipocyte progenitors in
the human subcutaneous fat does not exclude the possibility that
such progenitors could be found in other WAT depots in hu-
mans. In particular, it would be interesting to study the potential
presence of brown adipocyte progenitors in the BAT-like depots
detected by positron emission tomography in the upper part of
the human body [14].
The unique and tissue-specific potentiality of human muscle
CD34 cells to transform into brown adipocytes is consistent
with the observation that during normal development brown and
white adipocytes derive from different precursor cells [42, 43]
and with the recent demonstration that in rodent BAT brown
adipocytes share a common origin with myocytes but not with
white adipocytes [44]. Our results are in line with the recent
finding of Almind et al. [15], who showed UCP1-positive brown
fat cells in mouse intermuscular fat, but our study, using another
approach, goes one step further since it allows the identification
in the human skeletal muscle of the brown adipocyte progenitor
cells. Previously, white preadipocytes were also characterized as
CD34 cells [42]. It has also been shown that pericytes can
Figure 5. Effect of Rosi on UCP1 mRNA expression in human skeletal
muscle. Quantitative reverse transcription (RT)-polymerase chain reac-
tion (PCR) determination of UCP1 mRNA expression in the vastus
lateralis of obese diabetic patients before and after treatment with Rosi
(two doses of 4 mg each per day for 8 weeks). Since the RT-PCR
conditions used were different, the arbitrary values of this figure cannot
be compared with those of Figs. 2–4. The results are the means  SEM
of arbitrary values normalized using the corresponding cyclophilin A
values. n  7. , p  .05 versus control. Abbreviations: Rosi, rosigli-
tazone; UCP1, uncoupling protein-1.
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differentiate along the chondrocytic and adipocytic lineages in
vitro [45]. It has been found that fetal muscle CD34/CD146/
CD45/CD56 cells in an adipogenic medium different from
that used in the present study (i.e., consisting of DMEM con-
taining 10% fetal calf serum, 1 M dexamethasone, 0.5 M
isobutylmethylxanthine, 60 M indomethacin, and 170 M
insulin) differentiated into multilocular cells but that the latter
did not express UCP1 mRNA [38]. The CD146 and CD34
cells might therefore, under controlled culture conditions, dif-
ferentiate into white and brown adipocytes, respectively. It is
not known whether the brown adipocyte progenitors are the
ancestral CD34 cell or one particular endothelial CD34 cell
subtype [24]. Additional characterization and separation of the
CD34 cell pool would be necessary to answer this question.
In this study, the presence of a small but significant amount
of UCP1 mRNA in the adult human skeletal muscle was dem-
onstrated using quantitative RT-PCR. By analogy with the re-
sults obtained by Almind et al. [15] in mice, it can be assumed
that the low level of UCP1 detected in adult human muscle is
expressed by brown adipocytes infiltrating the muscle and not
by the muscle fibers. The microarray approach did not allow
detection of UCP1 in the adult human skeletal muscle, possibly
because it is less sensitive than the quantitative RT-PCR used.
Only one study, to our knowledge, has detected UCP1 mRNA in
human skeletal muscle [46]. These findings suggest that part of
the CD34 progenitors can differentiate into brown adipocytes
in the adult skeletal muscle, which opens the way for the
possibility of actively recruiting brown adipocytes in human
skeletal muscle via therapeutic targeting with potential antiobe-
sity drugs.
Moreover, two arguments suggest a physiological relevance
of our findings. First, our observation that cell-permeating
cAMP derivatives strongly stimulate UCP1 mRNA expression
in muscle CD34 cells in culture has a corollary in the finding
of Almind et al. [15], who showed that the administration of a
3-adrenoceptor agonist for 7 days dramatically increased (32-
fold) the UCP1 expression in obesity-resistant 129S6 mouse
muscle. Second, rosiglitazone not only increased UCP1 expres-
sion in muscle CD34 cells in long-term cultures but also
stimulated UCP1 expression in adult human skeletal muscle in
vivo. Thus, the pharmacological recruitment of CD34 muscle
progenitors into thermogenic cells in situ and, possibly, the
stimulation of UCP1 expression in these cells by specific -ad-
renoceptor or PPAR agonists might reveal a new maneuver
against obesity.
The identification of UCP1-expressing cell progenitors in
human muscle might be of therapeutic significance and lead to
the development of novel strategies against obesity. It was
estimated that in the adult human, a 20%–25% increase in
metabolic rate could be achieved by as little as 40–50 g of active
BAT. Twenty percent of daily energy expenditure could make
the difference between maintaining body weight and gaining
body weight at a rate of 20 kg per year [47]. Furthermore, it has
recently been shown that ectopic expression of very low levels
of UCP1 in the mouse epidydimal fat reverses a high-fat diet-
induced insulin and leptin resistance [48]. Consequently, autol-
ogous UCP1-expressing cells could be, after differentiation in
vitro from muscle CD34 progenitors, retransplanted into pa-
tients. However, the success of such a strategy depends on a
perfect control of brown adipocyte differentiation, to avoid the
emergence of white adipocytes from transplanted cells. Indeed,
the muscle niche might be more adequate to sustain white than
brown adipocyte differentiation, as revealed by the fatty infil-
tration observed in the muscle of patients with Duchenne mus-
cular dystrophy [49].
CONCLUSION
All the studies concerning UCP1 expression in adult humans
have until now been focused on the WAT. In the present study,
we showed for the first time the existence in skeletal muscle and
the prospective isolation of a reservoir of progenitor cells with
a high potential for brown adipogenic differentiation and UCP1
expression at all stages of the development and adult life. This
observation opens new avenues for fighting obesity by increas-
ing heat dissipation.
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